15-min delayed · Jul 27, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 1 firms covering 908 Devices Inc, 1 rate it Buy or better, 0 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. Targets are tightly clustered, $12.00 to $12.00, so the covering firms are broadly aligned. The average target of $12.00 sits 68% above the current $7.13. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $-0.08 next quarter toward $-0.29 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS1 ratings
Moderate Buy
Strong Buy00%
Buy1100%
Hold00%
Sell00%
Strong Sell00%
Based on 1 analysts giving stock ratings to 908 Devices Inc.
As of Jul, 1 of 1 firms rate MASS a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
MASS EPS & revenue forecast
EPS · NEXT QUARTER
$-0.08
Range $-0.12 – $-0.04 · 2 analysts · +82% YoY
Next period, 2 analysts expect 908 Devices Inc to earn $-0.08 a share (range $-0.12 – $-0.04), versus $-0.04 a year earlier. Full-year consensus is $-0.36, growing to $-0.29 the year after.
REVENUE · NEXT QUARTER
$18.6M
Range $17.7M – $20.1M · 2 analysts · +33% YoY
Revenue is expected to reach $18.6M (range $17.7M – $20.1M), +32.7% year-over-year. Full-year consensus is $68.6M, rising to $82.4M next year.
Top analysts covering 908 Devices Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on MASS.
#1
Puneet Souda
Leerink Partners
Buy
$12.00+68.4% to target
Coverage
—
+ Follow
MASS stock forecast FAQ
What is MASS's average 12-month price target?+
The 1 analysts with a live target average $12.00 for 908 Devices Inc over the next 12 months, ranging from a $12.00 high to a $12.00 low.
Is MASS stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 1 analyst ratings, 1 are Buy or Strong Buy, 0 are Hold, and 0 are Sell or Strong Sell.
How many Wall Street analysts cover MASS?+
1 analysts have an active rating on 908 Devices Inc, and 1 firms carry a live 12-month price target.
Who is the most accurate analyst covering MASS?+
Among analysts who currently cover MASS, Puneet Souda of Leerink Partners has the strongest overall Quantellect track record. Their current call is Buy with a $12.00 target.
What is 908 Devices Inc's projected EPS for next quarter?+
The consensus estimate is $-0.08 per share (range $-0.12 – $-0.04) across 2 analysts. Full-year EPS is projected at $-0.36, rising to $-0.29 the following year.
How much revenue is 908 Devices Inc expected to report next quarter?+
Consensus revenue is $18.6M (range $17.7M – $20.1M). Full-year revenue is projected at $68.6M, growing to $82.4M next year.
Have analysts been upgrading or downgrading MASS lately?+
As of Jul, 1 of 1 firms rate MASS a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their MASS calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.